Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 186
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

The Dogs of Chernobyl Research Initiative

The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

How does taking Ritalin affect depersonalization-derealization disorder patients?

We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

What is the role of copper and zinc dyshomeostasis in Alzheimer's disease pathology?

Alzheimer's Disease, the 6th leading cause of US deaths, is characterized by amyloid-beta(Aβ) plaques and...

Backer Badge Funded